Qing Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qing Liang has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Guangchun Sun
Department of Pharmacy, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, China
4 shared publications - Jing Liu
Department of Pharmacy, Fudan University, The Fifth People's Hospital of Shanghai, China
2 shared publications - Yan Yu
Department of Pharmacy, Fudan University, The Fifth People's Hospital of Shanghai, China
2 shared publications Beining Han
Department of Physical Education, Northeastern University, Shenyang 110819, China
1 shared publication- Benjamin Tomlinson
Seidman Cancer Center, University Hospitals Cleveland Medical Center
1 shared publication - Boglarka Gyurkocza
Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
1 shared publication
Latest Publications
- 2 August 2024
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 391 (1) , 39-50
Effect of Vascular Senescence on the Efficacy and Safety of Warfarin: Insights from Rat Models and a Prospective Cohort Study
Warfarin, with its narrow therapeutic range, requires the understanding of various influencing factors for personalized medication. Vascular senescence, marked by vascular stiffening and endothelial dysfunction, has an unclear effect on the efficacy and safety of warfarin. Based on previous studies, we hypothesized that vascular senescence increases the risk of bleeding during warfarin therapy. This study aimed to explore these effects using animal models and clinical cohorts. We established rat models of vascular senescence and calcification using d-galactose (D-Gal), vitamin D and nicotine (VDN). After validating the models, we examined changes in the International Normalized Ratio (INR) at fixed warfarin doses (0.20 and 0.35 mg/kg). We found that vascular senescence caused significantly elevated INR values and increasd bleeding risk. In the prospective clinical cohort study(NCT06428110), hospitalized warfarin patients with standard dose adjustments were divided into vascular senescence and control groups based on ultrasound and Computed Tomography (CT) diagnosis. Using propensity score matching (PSM) to exclude the influence of confounding factors, we found that the vascular senescence group had lower steady-state warfarin doses and larger dose adjustments, with a higher probability of INR exceeding the therapeutic range. The vascular senescence group tended to experience more bleeding or thromboembolic/ischemic events during one year of follow-up, while there was no statistical difference. In conclusion, vascular senescence leads to unstable INR values and increases higher bleeding risk during warfarin therapy, highlighting the importance of considering vascular senescence in future precision warfarin therapies. Significance Statement Many factors influence warfarin efficacy, however, the effect of vascular senescence remains unclear. This study aimed to investigate the effects of vascular senescence on the efficacy and safety of warfarin. Through both rat models and clinical cohort studies, our findings indicated that vascular senescence may compromise the stability of warfarin, presenting challenges in maintaining its efficacy and safety.
- 2 August 2024
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 391 (1) , 39-50
Effect of Vascular Senescence on the Efficacy and Safety of Warfarin: Insights from Rat Models and a Prospective Cohort Study
Warfarin, with its narrow therapeutic range, requires the understanding of various influencing factors for personalized medication. Vascular senescence, marked by vascular stiffening and endothelial dysfunction, has an unclear effect on the efficacy and safety of warfarin. Based on previous studies, we hypothesized that vascular senescence increases the risk of bleeding during warfarin therapy. This study aimed to explore these effects using animal models and clinical cohorts. We established rat models of vascular senescence and calcification using d-galactose (D-Gal), vitamin D and nicotine (VDN). After validating the models, we examined changes in the International Normalized Ratio (INR) at fixed warfarin doses (0.20 and 0.35 mg/kg). We found that vascular senescence caused significantly elevated INR values and increasd bleeding risk. In the prospective clinical cohort study(NCT06428110), hospitalized warfarin patients with standard dose adjustments were divided into vascular senescence and control groups based on ultrasound and Computed Tomography (CT) diagnosis. Using propensity score matching (PSM) to exclude the influence of confounding factors, we found that the vascular senescence group had lower steady-state warfarin doses and larger dose adjustments, with a higher probability of INR exceeding the therapeutic range. The vascular senescence group tended to experience more bleeding or thromboembolic/ischemic events during one year of follow-up, while there was no statistical difference. In conclusion, vascular senescence leads to unstable INR values and increases higher bleeding risk during warfarin therapy, highlighting the importance of considering vascular senescence in future precision warfarin therapies. Significance Statement Many factors influence warfarin efficacy, however, the effect of vascular senescence remains unclear. This study aimed to investigate the effects of vascular senescence on the efficacy and safety of warfarin. Through both rat models and clinical cohort studies, our findings indicated that vascular senescence may compromise the stability of warfarin, presenting challenges in maintaining its efficacy and safety.
- 9 March 2023
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 24 (4) , 227-237
Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention
Background: The effect of multiple mutations in CYP2C19, PON1 and ABCB1 genes on the effectiveness and safety of dual antiplatelet therapy after percutaneous coronary intervention remains unclear. ... Plain language summary The effects of different combinations of mutations in the genes CYP2C19, PON1 and ABCB1 on the effectiveness and safety of dual antiplatelet therapy in patients who undergo p... Tweetable abstract Multiple genetic mutations influence platelet response and thrombosis risk with clopidogrel and aspirin after percutaneous coronary intervention.
- 9 March 2023
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 24 (4) , 227-237
Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention
Background: The effect of multiple mutations in CYP2C19, PON1 and ABCB1 genes on the effectiveness and safety of dual antiplatelet therapy after percutaneous coronary intervention remains unclear. ... Plain language summary The effects of different combinations of mutations in the genes CYP2C19, PON1 and ABCB1 on the effectiveness and safety of dual antiplatelet therapy in patients who undergo p... Tweetable abstract Multiple genetic mutations influence platelet response and thrombosis risk with clopidogrel and aspirin after percutaneous coronary intervention.
- Open Access
- 1 March 2021
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 27 (3) , S56
Myeloablative Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Spares the GI Tract and Has Low Incidence of Severe Mucositis, Febrile Neutropenia and Sepsis in the Prospective, Randomized Phase 3 Sierra Trial for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- 1 March 2021
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 27 (3) , S56
Open AccessMyeloablative Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Spares the GI Tract and Has Low Incidence of Severe Mucositis, Febrile Neutropenia and Sepsis in the Prospective, Randomized Phase 3 Sierra Trial for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Open Access
- 1 January 2021
- Published by Francis Academic Press Ltd. in Frontiers in Sport Research
- Vol. 3 (1)
The Application Dilemma and Innovative Path of "MOOC+ Flipped Classroom" Model in Physical Education Classrooms in Primary and Middle Schools
Using literature and other methods to analyze the plight and path of the "MOOC+Flipped classroom" teaching model in physical education classrooms in elementary and middle schools, the research found: The deviation between two-dimensional video presentation and three-dimensional physical exercises, the double dilemma of the Internet and physical education in primary and secondary schools, the lack of directivity of teaching videos, and the misunderstanding of teachers’ teaching are the main elements of physical education in the current "MOOC+Flipped classroom" model. It is necessary to reasonably position the role of MOOC in the physical education teaching process, properly preview and strengthen review; improving the platform network environment, popularizing the recognition of movement concepts and strengthen the pertinence of videos, and reshaping the new concepts of "teaching" and "learning" to solve the existing problems.
- 1 January 2021
- Published by Francis Academic Press Ltd. in Frontiers in Sport Research
- Vol. 3 (1)
Open AccessThe Application Dilemma and Innovative Path of "MOOC+ Flipped Classroom" Model in Physical Education Classrooms in Primary and Middle Schools
Using literature and other methods to analyze the plight and path of the "MOOC+Flipped classroom" teaching model in physical education classrooms in elementary and middle schools, the research found: The deviation between two-dimensional video presentation and three-dimensional physical exercises, the double dilemma of the Internet and physical education in primary and secondary schools, the lack of directivity of teaching videos, and the misunderstanding of teachers’ teaching are the main elements of physical education in the current "MOOC+Flipped classroom" model. It is necessary to reasonably position the role of MOOC in the physical education teaching process, properly preview and strengthen review; improving the platform network environment, popularizing the recognition of movement concepts and strengthen the pertinence of videos, and reshaping the new concepts of "teaching" and "learning" to solve the existing problems.
- 4 October 2020
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 35 (4) , 690-699
Valproic acid reverses sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common lethal human malignancies worldwide. Sorafenib is the first‐line drug approved by the United States Food and Drug Administration for HCC. However, the acquired resistance to sorafenib reduces its beneficial effects and limits clinical use. In this study, we established a sorafenib‐resistant HCC cell line HepG2‐SR by low‐concentration gradient induction. Compared with the parental cell HepG2, the proliferation and anti‐apoptosis were increased in drug‐resistant cell HepG2‐SR. Thorough comparisons of the molecular changes between parental HepG2 and sorafenib‐resistant HepG2‐SR cells indicated that the Notch signaling pathway and PI3K/Akt signaling pathway were associated with sorafenib resistance mechanisms. Notch1 and Akt were upregulated in sorafenib‐resistant cells. However, we surprisingly found that valproic acid (VPA) combined with sorafenib could enhance the sensitivity of drug‐resistant cells and reverse the increased levels of Notch1 and Akt in sorafenib‐resistant HCC cells. Moreover, Akt inhibitor could suppress Notch1 expression, whereas the level of Akt phosphorylation decreased along with increasing dose of Notch inhibitor. Besides, we found that knockdown of Akt resulted in Notch1 reduction, whereas Notch1 reduction also led to a significant reduction in the phosphorylation of Akt. Collectively, our results indicated that Notch1 and Akt might play vital roles in sorafenib resistance in HCC cells and VPA might overcome the drug resistance to enhance the sensitivity of HCC cells to sorafenib through suppressing Notch/Akt signaling pathway. VPA combined with sorafenib may provide a potential targeting therapeutic regimen for clinically to solve the problem of sorafenib resistance.
- 4 October 2020
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 35 (4) , 690-699
Valproic acid reverses sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common lethal human malignancies worldwide. Sorafenib is the first‐line drug approved by the United States Food and Drug Administration for HCC. However, the acquired resistance to sorafenib reduces its beneficial effects and limits clinical use. In this study, we established a sorafenib‐resistant HCC cell line HepG2‐SR by low‐concentration gradient induction. Compared with the parental cell HepG2, the proliferation and anti‐apoptosis were increased in drug‐resistant cell HepG2‐SR. Thorough comparisons of the molecular changes between parental HepG2 and sorafenib‐resistant HepG2‐SR cells indicated that the Notch signaling pathway and PI3K/Akt signaling pathway were associated with sorafenib resistance mechanisms. Notch1 and Akt were upregulated in sorafenib‐resistant cells. However, we surprisingly found that valproic acid (VPA) combined with sorafenib could enhance the sensitivity of drug‐resistant cells and reverse the increased levels of Notch1 and Akt in sorafenib‐resistant HCC cells. Moreover, Akt inhibitor could suppress Notch1 expression, whereas the level of Akt phosphorylation decreased along with increasing dose of Notch inhibitor. Besides, we found that knockdown of Akt resulted in Notch1 reduction, whereas Notch1 reduction also led to a significant reduction in the phosphorylation of Akt. Collectively, our results indicated that Notch1 and Akt might play vital roles in sorafenib resistance in HCC cells and VPA might overcome the drug resistance to enhance the sensitivity of HCC cells to sorafenib through suppressing Notch/Akt signaling pathway. VPA combined with sorafenib may provide a potential targeting therapeutic regimen for clinically to solve the problem of sorafenib resistance.
- Open Access
- 21 January 2020
- Published by Hindawi Limited in Andrologia
- Vol. 52 (3) , e13517
Primary rhabdomyosarcoma of tunica vaginalis misdiagnosing as hydrocele: A case report and literature review
Primary rhabdomyosarcoma of tunica vaginalis is very rare. We report a case of a 15‐year‐old man presenting as hydrocele. Pre‐operatively, no masses were detected by ultrasonography. Hydrocelectomy was performed. At surgery, a 0.8 cm polypoid nodule and diffusely thickened tunica were found. Pathologic examination finally revealed rhabdomyosarcoma. A PET‐CT was then performed and indicated scrotal implantation metastasis. The patient underwent radical inguinal orchiectomy and was treated with chemotherapy and radiotherapy after surgery. At 12 months of follow‐up, he remained disease‐free.
- 21 January 2020
- Published by Hindawi Limited in Andrologia
- Vol. 52 (3) , e13517
Open AccessPrimary rhabdomyosarcoma of tunica vaginalis misdiagnosing as hydrocele: A case report and literature review
Primary rhabdomyosarcoma of tunica vaginalis is very rare. We report a case of a 15‐year‐old man presenting as hydrocele. Pre‐operatively, no masses were detected by ultrasonography. Hydrocelectomy was performed. At surgery, a 0.8 cm polypoid nodule and diffusely thickened tunica were found. Pathologic examination finally revealed rhabdomyosarcoma. A PET‐CT was then performed and indicated scrotal implantation metastasis. The patient underwent radical inguinal orchiectomy and was treated with chemotherapy and radiotherapy after surgery. At 12 months of follow‐up, he remained disease‐free.
- 4 October 2019
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 20 (9) , 701-713
Interaction between Traditional Chinese Medicine and Anticoagulant/Antiplatelet Drugs
Background: Traditional Chinese medicine (TCM) has been used for medical purposes since the ancient time and has gradually gained recognition worldwide. Nowadays, patients with thrombus presiding to anticoagulant/ antiplatelet drugs prefer taking TCM. However, an increasing number of studies on herb–drug interactions have been shown. Nevertheless, findings are frequently conflicting and vague. In this review, we discuss the herb–drug interactions between TCM and anticoagulant/antiplatelet drugs to provide guidance on concomitant ingestion with anticoagulant/antiplatelet drugs. Methods: We undertook a structured search of medicine and drug databases for peer-reviewed literature using focused review questions. Results: Danshen, Ginkgo, Ginger, H. Perforatum, SMY and Puerarin injection had directional regulation effects on the efficacy of anticoagulant drugs by altering the CYPs, pharmacokinetic indexs and hemorheological parameters. H. Perforatum inhibited the efficacy of Clopidogrel by enhancing the CYP3A4 activity and Ginkgo increased the efficacy of Ticlopidine. Additionally, Renshen, the formulae except SMY and injections except Puerarin injection could increase or decrease the efficacy of anticoagulant/antiplatelet drugs via regulating the CYPs, platelet aggregation, hemorheological parameters and others. Conclusion: Some cases have reported that TCMs may increase the bleeding risk or has no effect on coagulation when anticoagulant/antiplatelet drugs are concurrently used. However, pharmacokinetic studies have presented either consistent or slightly varying results. So it is difficult to ascertain whether the concurrent use of TCM may increase or reduce the pharmacologic effects of anticoagulant/antiplatelet drugs with adverse reactions. Therefore, herb–drug interactions of TCM and anticoagulant/antiplatelet drugs should be further explored and defined.
- 4 October 2019
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 20 (9) , 701-713
Interaction between Traditional Chinese Medicine and Anticoagulant/Antiplatelet Drugs
Background: Traditional Chinese medicine (TCM) has been used for medical purposes since the ancient time and has gradually gained recognition worldwide. Nowadays, patients with thrombus presiding to anticoagulant/ antiplatelet drugs prefer taking TCM. However, an increasing number of studies on herb–drug interactions have been shown. Nevertheless, findings are frequently conflicting and vague. In this review, we discuss the herb–drug interactions between TCM and anticoagulant/antiplatelet drugs to provide guidance on concomitant ingestion with anticoagulant/antiplatelet drugs. Methods: We undertook a structured search of medicine and drug databases for peer-reviewed literature using focused review questions. Results: Danshen, Ginkgo, Ginger, H. Perforatum, SMY and Puerarin injection had directional regulation effects on the efficacy of anticoagulant drugs by altering the CYPs, pharmacokinetic indexs and hemorheological parameters. H. Perforatum inhibited the efficacy of Clopidogrel by enhancing the CYP3A4 activity and Ginkgo increased the efficacy of Ticlopidine. Additionally, Renshen, the formulae except SMY and injections except Puerarin injection could increase or decrease the efficacy of anticoagulant/antiplatelet drugs via regulating the CYPs, platelet aggregation, hemorheological parameters and others. Conclusion: Some cases have reported that TCMs may increase the bleeding risk or has no effect on coagulation when anticoagulant/antiplatelet drugs are concurrently used. However, pharmacokinetic studies have presented either consistent or slightly varying results. So it is difficult to ascertain whether the concurrent use of TCM may increase or reduce the pharmacologic effects of anticoagulant/antiplatelet drugs with adverse reactions. Therefore, herb–drug interactions of TCM and anticoagulant/antiplatelet drugs should be further explored and defined.